Newsroom | 28637 results

NUEVA YORK--(BUSINESS WIRE)--Blue Matter tiene el orgullo de anunciar que ha establecido un área de práctica que prestará exclusivamente servicios a los clientes en investigación y desarrollo (I+D) biofarmacéutico. La dirección de esta práctica estará a cargo de Tara Austraat-Churik, una socia que se incorporó a la firma en septiembre de 2025. Tara Austraat-Churik tiene más de 20 años de experiencia en servicios a los clientes del sector de las ciencias de la vida. Se ha especializado en las ár...

NEW YORK--(BUSINESS WIRE)--Blue Matter a le plaisir d'annoncer la création d'un domaine d'expertise dédié aux clients du secteur de la recherche et développement biopharmaceutique. Ce domaine est dirigé par l'associée Tara Austraat-Churik, qui a rejoint le cabinet en septembre 2025. Tara Austraat-Churik accompagne les acteurs des sciences de la vie depuis plus de 20 ans. Ses domaines d'expertise comprennent le développement et la mise en œuvre de stratégies, la conception de modèles opérationne...

NEW YORK--(BUSINESS WIRE)--Blue Matter annuncia la creazione di una nuova area di consulenza dedicata ai clienti del settore R&S biofarmaceutico e diretta da Tara Austraat-Churik, partner unitasi a Blue Matter nel settembre 2025. Tara Austraat-Churik vanta un’esperienza di oltre 20 anni al servizio di clienti nel settore delle scienze della vita. Molteplici le sue aree di competenza – sviluppo e implementazione di strategie, progettazione di modelli operativi e organizzativi, ottimizzazione...

NEW YORK--(BUSINESS WIRE)--Blue Matter hat einen neuen Praxisbereich gegründet, der auf die Bedürfnisse von Kunden aus der biopharmazeutischen Forschung und Entwicklung (FuE) ausgerichtet ist. Geleitet wird der Praxisbereich von Tara Austraat-Churik, einer Partnerin, die seit September 2025 für Blue Matter tätig ist. Tara Austraat-Churik ist bereits seit über 20 Jahren für Life-Science-Kunden tätig. Ihre Schwerpunkte sind Strategieentwicklung und -umsetzung, Betriebsmodell- und Organisationsges...

SAN FRANCISCO--(BUSINESS WIRE)--On the occasion of the 44th J.P. Morgan Healthcare Conference in San Francisco, Bayer AG today unveiled the strategic focus for its Pharmaceuticals Division in 2026. Capitalizing on new launch momentum, the company will drive significant global regulatory expansions and market penetration across its pharmaceutical portfolio. High-value commercial products and an accelerating modality-rich pipeline across oncology, cardiology, neurology, and immunology have firmly...

NEW YORK--(BUSINESS WIRE)--Blue Matter kondigt met trots de oprichting aan van een praktijkgroep die zich richt op klanten in de biofarmaceutische sector, specifiek op het gebied van onderzoek en ontwikkeling (R&D). Deze praktijkgroep wordt geleid door Tara Austraat-Churik, een partner die in september 2025 bij het bedrijf is komen werken. Tara Austraat-Churik heeft meer dan 20 jaar ervaring in de biowetenschappelijke sector. Haar expertise omvat strategieontwikkeling en -implementatie, ope...

COLUMBUS, Ohio--(BUSINESS WIRE)--Battelle has been selected as one of 10 companies awarded contracts under the Defense Microelectronics Activity’s (DMEA) Advanced Technology Support Program V (ATSP V). The 10-year, government-wide, multiple award Indefinite Delivery/Indefinite Delivery (IDIQ) contract vehicle has a ceiling of $25.35 billion, to rapidly provide engineering solutions for electronics and software problems. Under the contract, Battelle will deliver engineering development capabilit...

ATLANTA--(BUSINESS WIRE)--Dr. Taz Bhatia, a leading expert in modernized holistic medicine, integrating traditional healing with contemporary medical advancements, has reimagined the future of health with the launch of hol+. This new functional medical home combines the best of eastern and western medicine to create a one stop shop for primary and consultative care, utilizing a holistic approach. hol+, founded by triple board-certified physician and integrative medicine pioneer Dr. Taz Bhatia,...

NEW YORK--(BUSINESS WIRE)--Blue Matter is pleased to announce that it has established a practice area dedicated to serving clients in biopharmaceutical Research & Development (R&D). The practice is led by Tara Austraat-Churik, a Partner who joined the firm in September 2025. Tara Austraat-Churik has been serving life science clients for more than 20 years. Her areas of expertise include strategy development and implementation, operating model and organizational design, and process optim...

RALEIGH, N.C.--(BUSINESS WIRE)--Univo IRB, today’s fastest-growing central institutional review board (IRB), announced it has successfully completed a routine inspection by the U.S. Food and Drug Administration (FDA) with no findings. The outcome exemplifies Univo IRB’s unwavering commitment to protecting research participants and upholding the highest standards of ethical and regulatory oversight in clinical research. “This inspection result reflects our expertise, diligence, and continued foc...